Skip to main content
. 2012 May 23;7(5):e37883. doi: 10.1371/journal.pone.0037883

Table 2. Predictors of events.

Outcome; mean survival, days (p – value)
Predictor Death AMI HF
Plasma betaine middle quintiles 1390 1332 1373
Plasma betaine high (>60.6 µmol/L) 1434 (0.7) 1294 (0.18) 1321 (0.043)
Plasma betaine low (<33.8 µmol/L) 1354 (0.6) 1198 (0.014) 1336 (0.5)
Plasma DMG middle quintiles 1441 1252 1379
Plasma DMG high (>5.8 µmol/L) 1270 (<0.001) 1155 (0.004) 1245 (0.027)
Plasma DMG low (<2.5 µmol/L) 1340 (0.3) +0.4 (0.5) 1377 (0.12)
Urine betaine excr. middle quintiles 1406 1349 1444
Urine betaine excr. high (>19.5) 1390 (0.5) 1283 (0.6) 1276 (0.005)
Urine betaine excr. low (<4.6) 1425 (0.055) 1301 (0.9) 1291 (0.013)
Plasma homocysteine middle quintiles 1441 1380 1434
Plasma homocysteine high (>17.0 µmol/L) 1215 (<0.001) 930 (<0.001) 987 (<0.001)
Plasma homocysteine low (<10.0 µmol/L) 1459 (0.13) 1390 (0.6) 1459 (0.092)

Comparisons of the middle three quintiles with the top quintile (“high”) and lowest quintile (“low”) for possible predictors of events. Mean survival times to events given in days, with p values (in brackets) for the difference in risk compared with the middle 60% of the population. Significant (p<0.05) statistics are in bold. DMG: N,N-dimethylglycine. AMI: acute MI. HF: hospital admission for heart failure. Betaine excretions expressed as mmol betaine/mole creatinine. Plasma betaine and DMG concentrations are gender corrected; male values cited (female values 17% lower for betaine, 10% lower for DMG).